‘Remove criteria to trastuzumab accessibility’

  • Nation
  • Monday, 15 Apr 2019

KUALA LUMPUR: While a patient group and an oncologist welcome the big price drop of trastuzumab, a breast cancer drug for HER2-positive patients, they urge the Health Ministry to remove the limiting criteria for selecting HER2+ patients to be treated.

Instead, they said HER2-positive patients should be given the choice to be treated regardless of age and cancer stage.

Get 30% off with our ads free Premium Plan

Monthly Plan


Annual Plan


Billed as RM103.60/year

1 month

Free Trial

For new subscribers only

Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Nation

DAP's New Year billboards vandalised in Penang
Malaysia agrees to increase financial aid to UNRWA, says Anwar
Senior citizens among six nabbed in RM4mil drug bust
What’s the status of carbon credit deal, Warisan rep asks Sabah govt
'GOLD' number plate revenue helps cover bus and taxi drivers' Socso contributions, says Loke
Round-the-clock police patrols in KK after spate of robberies
Locum docs at public healthcare facilities to get allowances right away, says Dr Zul
Two killed, two hurt in Puchong factory blast
Defence Minister to look into LTAT resignations and brief Cabinet, says PM
Upgraded Sabah Trade Centre will drive SME growth, says minister

Others Also Read